NIOSH Expands List of Drugs Dangerous to Health Workers

Thirty-four new drugs have been added. "The NIOSH 2016 Hazardous Drug List is an important resource as well as a tool to raise awareness among workers about the hazards some drugs, enabling workers to take the necessary steps to protect themselves from exposure while doing their job," said NIOSH Director Dr. John Howard, M.D., MPH.

  • Oct 10, 2016

NIOSH has released its 2016 list of hazardous drugs in health care settings, an updated list that include 34 additional drugs. Health workers who prepare or give hazardous drugs to patients, such as those used for cancer therapy, and support staff may be at risks when exposed to these drugs; NIOSH estimates 8 million U.S. health workers are potentially exposed to hazardous drugs in the workplace.

The new document, "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016," is the latest version of a list first published by NIOSH in 2004 as an appendix to an Alert about antineoplastic and other hazardous drugs used in health care settings.

"Hazardous drugs include those used for cancer chemotherapy, antiviral drugs, hormones, some bioengineered drugs, and other examples of hazardous drugs," said NIOSH Director Dr. John Howard, M.D., MPH. "The NIOSH 2016 Hazardous Drug List is an important resource as well as a tool to raise awareness among workers about the hazards some drugs, enabling workers to take the necessary steps to protect themselves from exposure while doing their job."

This list categorizes drugs into these groups: 1) antineoplastic drugs 2) non-antineoplastic hazardous drugs, and 3) drugs with reproductive effects. And it includes 34 drugs not found on previous lists, five of which include the manufacturer's safe handling warnings; general guidance on engineering controls and personal protective equipment for various activities that may be encountered in health care settings have been updated.

For more information on hazardous drug exposures in health care, visit: http://www.cdc.gov/niosh/topics/hazdrug/.

Product Showcase

  • Matrix's OmniPro Vision AI Collision Avoidance System

    OmniPro Vision AI is a state-of-the-art collision avoidance system that features NIOSH award-winning Visual Artificial Intelligence (AI) technology. This highly accurate, powerful system identifies and alerts on pedestrians, vehicles and specified objects, ensuring safer facilities, mining operations and industrial sites. With its web-based cloud application, OmniPro Vision AI also logs and analyzes a wide range of data related to zone breach notifications. Operating without needing personal wearable devices or tags, OmniPro has visual and audible zone breach alerts for both operators and pedestrians. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

Featured

Most   Popular

Artificial Intelligence

Webinars